The crystal structure is shown in the gure. Tables 1 and  2 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
. 
Source of material
Reaction of 3-(benzofuran-2-yl)-5-(4-uorophenyl)-4,5-dihydro-1H-pyrazole-1-carbothioamide and 2-bromo-1-(4-chlorophenyl)ethanone in ethanol under re ux for 3 h provided the crude product. Crystallization from dimethylformamide gave colorless crystals of the title compound (Mp 176-178°C) [1] .
Experimental details
Cell re nement and data reduction were carried out by Bruker SAINT [6] .
Discussion
Pyrazolylthiazole derivatives exhibit anti-in ammatory [2] , antimicrobial activities [2] and cause antinociception in mice [3] . Also, some derivatives are useful as DF508-cystic brosis transmembrane conductance regulators that have improved hydrophilicity compared to bithiazoles [4] .
The asymmetric unit of the title structure contains only one independent molecule with a central pyrazol ring (N1/N2/C9-C11) which makes dihedral angles of 1.05 (2)°, 2.85 (2)°and 77.25 (3)°with benzofuran ring (O1/C1-C8), thiazol ring (S1/C18/N3/C19/C20) and uorophenyl ring (C12-C17), respectively. There is one hydrogen bond: C23-H23A· · · F1 i with symmetry code: i = −x+1, y+1/2, −z+1/2.
